Jumin Huang
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Toxicology top 10%
Papers in
-
- Ginseng Biological Effects and Applications 5
- Gut microbiota and health 4
- Oncology 9
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Elaine Lai‐Han Leung (20 shared papers)Zebo Jiang (13 shared papers)Xing‐Xing Fan (10 shared papers)Qibiao Wu (8 shared papers)Chun Xie (7 shared papers)Ya‐Jia Xie (7 shared papers)Wenjun Wang (6 shared papers)Peiyu Yan (5 shared papers)
- Journals
- Pharmacological Research (10 papers)Nature Communications (2 papers)Acta Pharmaceutica Sinica B (1 paper)Cell Death and Disease (1 paper)Current Opinion in Pharmacology (1 paper)
- Partner nations
- MacaoChinaUnited States
In The Last Decade
Jumin Huang
25 papers receiving 828 citations
Jumin Huang's Hit Papers
Peers
Comparison fields: 5 of 88
- Cancer Research 124
- Toxicology 27
- Oncology 207
- Pharmacology 57
- Immunology 136
Countries citing papers authored by Jumin Huang
This map shows the geographic impact of Jumin Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jumin Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jumin Huang more than expected).
Fields of papers citing papers by Jumin Huang
This network shows the impact of papers produced by Jumin Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jumin Huang. The network helps show where Jumin Huang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jumin Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer Hit paper breakdown → | 2021 | 177 |
| 2 | 2020 | 93 | |
| 3 | 2021 | 67 | |
| 4 | 2023 | 64 | |
| 5 | 2019 | 48 | |
| 6 | 2022 | 46 | |
| 7 | 2020 | 45 | |
| 8 | 2023 | 36 | |
| 9 | 2021 | 33 | |
| 10 | 2020 | 30 | |
| 11 | 2018 | 28 | |
| 12 | Selective utilization of medicinal polysaccharides by human gut Bacteroides and Parabacteroides species Hit paper breakdown → | 2025 | 25 |
| 13 | 2023 | 19 | |
| 14 | 2022 | 19 | |
| 15 | 2024 | 18 | |
| 16 | 2023 | 14 | |
| 17 | 2023 | 14 | |
| 18 | 2023 | 13 | |
| 19 | 2024 | 12 | |
| 20 | 2023 | 10 |
About Jumin Huang
Jumin Huang is a scholar working on Molecular Biology, Oncology, Immunology, Pulmonary and Respiratory Medicine and Genetics, having authored 25 papers that have together received 832 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Ginseng Biological Effects and Applications (5 papers), Immune Cell Function and Interaction (4 papers), Gut microbiota and health (4 papers), Immune cells in cancer (4 papers), Phagocytosis and Immune Regulation (2 papers), Cancer Research and Treatments (2 papers) and Bacteriophages and microbial interactions (2 papers). The work is most often cited by research in Cancer Research (124 citations), Toxicology (27 citations), Oncology (207 citations), Pharmacology (57 citations) and Immunology (136 citations). Jumin Huang has collaborated with scholars based in Macao, China and United States. Frequent co-authors include Elaine Lai‐Han Leung, Zebo Jiang, Xing‐Xing Fan, Qibiao Wu, Chun Xie, Ya‐Jia Xie, Wenjun Wang, Peiyu Yan, Xuan‐Run Wang and Xiaojun Yao. Their work appears in journals such as Pharmacological Research, Nature Communications, Acta Pharmaceutica Sinica B, Cell Death and Disease and Current Opinion in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.